About Us

Curve transition
Joshuasteinmd
Joshua Stein, MD
Dr. Stein is a board certified urologist who has been in practice since 2008. He received an undergraduate degree from the University of Pennsylvania in Systems Engineering and received his medical degree at the University of Connecticut. This was followed by a general surgery internship and residency in urology at Yale New Haven Hospital/ Yale School of Medicine

Over the course of his career, Dr Stein has provided urologic care to patients in many areas, including urologic cancer, andrology and men's health, infertility, BPH and management of stone disease. Current areas of interest include minimally invasive treatment for BPH, kidney stones and prostate cancer.

In his most recent clinical position, Dr Stein has served as a urologist and director of the Kidney Stone Clinical Council at Hartford Healthcare in Hartford, CT. He also is the founder and director of the Tallwood Kidney Stone Center. 
Kaihanshammerichmdphd
Kai Hans Hammerich, MD PhD
Dr. Hammerich is a board certified urologist who has been in practice since 2009.

In 2004, Dr. Hammerich received his medical degrees with honors from the University of Hamburg, Germany.

After completing a 3-year postdoctoral fellowship in The Prostate Cancer Research Lab at the Baylor College of Medicine in Houston, Texas, Dr. Hammerich went to the Lahey Hospital and Medical Center in Burlington, MA, where he finished his Urology Residency in 2015.

Following this, Dr. Hammerich joined the Urologic Oncology Branch of the Center for Cancer Research at the National Cancer Institute (NCI), National Institutes of Health (NIH), where he accomplished a two-year clinical fellowship in Urologic Oncology, with a focus on robotic surgeries of complex urologic malignancies.

From 2017 until 2024, Dr. Hammerich was functioning as a Medical Director of Urology in central Connecticut. Beside providing compassionate care to patients in General Urology, one of Dr. Hammerich's clinical interests is organ and functional preservation, using surgical techniques such as partial nephrectomy for kidney cancer and nerve-sparing radical prostatectomy.

Dr. Hammerich has engaged in extensive clinical and basic research in prostate cancer, localized or metastatic/progressive disease, the identification of diagnostic tools and techniques, and the development of novel multimodal treatment strategies. He is widely published in the field of urology and oncology, and he has been a visiting professor in Germany, United Kingdom, and Switzerland.

Dr. Hammerich is married and has 4 children.